DD01

· Neuraly, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DD01, covering 2024-04-29 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH [Phase 2]